Congrats to Dr. Melanie Ecker for Accepting a Tenure-track Faculty Position at UNT
We are pleased to announce that Melanie has accepted the offer for the position of Assistant Professor in the Department of Biomedical Engineering at the University of North Texas. She will become a junior faculty with the fall 2019 semester and will start her own lab. We wish you all the best!
Over the past 5 years, gene editing has grown from a niche field with a few candidate technologies into a major pillar of biomedical research. These technologies hold promise for treating diseases in many different organ systems in the coming decades, but translation to human patients is still handicapped by a major obstacle: Delivery of gene editors into the human body. In this talk, we will explore the current state-of-the-art for delivering gene editors to the central and peripheral nervous system. We will then look at future avenues for improving delivery methods and what the treatment of neurological disorders with gene therapy may look like in the not-so-distant future.
The Center for BrainHealth invites scientists to share their scientific study with students and other researchers at the Frontiers of BrainHealth Lunch Lectures.
Next week, on Friday June 14th, Dr. Kildebeck will discuss his research at the Frontiers Scientific Lecture Series.
The lectures are heavily science focused and are not intended for a lay audience. These lectures are free, but you must register to reserve your seat. Lunch is served at 11:45 AM.
On June 6, 2019, Prof. Voit will give a Google Tech Talk in Mountain View, CA detailing his team’s work in high throughput additive manufacturing. Dr. Voit will discuss the recent launch of the world’s softest, tough additive photopolymer, Soft ToughRubberTM at the RAPID + TCT tradeshow in Detroit this past May, and his team’s efforts in software design and materials design to attempt to change how the world mass manufactures polymers. Adaptive3D closed a Series A funding round in January (2019) co-led by the venture arms of The Royal DSM and Applied Materials with support from Chemence and a founding family of Texas Instruments, the McDermott family. The company does business in five key market verticals: Transportation, Oil & Gas, Medical, Industrial and Consumer. Adaptive3D has also announced a strategic distribution agreement with DSM and a strategic manufacturing agreement with Chemence within the past quarter. Adaptive3D is commercializing technology licensed from UT Dallas.